KRAS and Patent ductus arteriosus: MIA-PaCa2, BxPC-3, primary PDA cells PacaDD-183 and CRL 1097 non-malignant pancreatic ductal cells were treated with dietary agents alone or in combination and 72 h later the expression of the miR-let-7a and its target gene K-ras was examined by qRT-PCR.